Get Rid of This Tabacco Stock BEFORE the Week Ends

: GNLN | Greenlane Holdings, Inc. - News, Ratings, and Charts

GNLN – Greenlane Holdings (GNLN) has delivered a poor performance over the past year, greatly dismaying investors. Moreover, the company is struggling with expanding losses. While a return to profitability appears uncertain, let’s look at some of its metrics to understand why it is best to steer clear of GNLN…

Greenlane Holdings, Inc. (GNLN) has experienced a 96.1% drop in its stock price over the past year and remains below $1 – closing at just $0.31 in the last trading session. In the last month of 2022, Nasdaq issued a noncompliance notice to GNLN, giving the company until June 12 to raise its minimum bid to $1 to avoid delisting.

The company’s financial struggles have been evidenced by the broadening of losses and declining revenues. What are the next steps for GNLN to regain profitability? It remains uncertain, but it is important to examine some of the metrics that provide insight into the company’s current state.

Examining GNLN’s Dramatic Net Income Decline Over a Two-Year Period

The net income of GNLN had seen a general downward trend since June 2020, when it was $15.9 million. The last reported value in December 2022 was $115.8 million, a 633% increase in losses from June 2020. The losses fluctuated during this period, especially from September 2021 to September 2022, when the losses increased from $27.1 million to $109.6 million.

The trend of GNLN’s revenue over the two-year period from June 30, 2020, to December 31, 2022, has seen an overall increase. The revenue has fluctuated somewhat, with a significant decrease in the September 30, 2022, figures down to $171.15 million.

Decline of 72%: GNLN Share Price Over 6-Month Period

The overall trend of the data is a decrease in the share price of GNLN. Over the 6-month period from October 2022 to April 2023, the share price went from $1.10 to $0.31, representing a decline of 72%. The rate of decrease was decelerating, with the most significant drops occurring early in the period. Here is a chart of GNLN’s price over the past 180 days.

Unfavorable POWR Ratings

The overall rating of GNLN has been consistently at a D since October 29, 2022, which translates to a Sell in our POWR Ratings system. Also, it is ranked last in the 10-stock Tobacco category. The POWR Ratings are calculated considering 118 distinct factors, with each factor weighted to an optimal degree.

Our proprietary rating system also evaluates each stock based on eight distinct categories. The stock has an F grade for Stability and Quality and a D for Momentum and Sentiment.

Stocks to Consider Instead of Greenlane Holdings, Inc. (GNLN)

Other stocks in the Tobacco sector that may be worth considering are British American Tobacco Industries p.l.c. ADR (BTI), Japan Tobacco Inc. (JAPAY), and Vector Group Ltd. (VGR) — have better POWR Ratings.

The Bear Market is NOT Over…

That is why you need to discover this timely presentation with a trading plan and top picks from 40 year investment veteran Steve Reitmeister:

REVISED: 2023 Stock Market Outlook > 

Want More Great Investing Ideas?

3 Stocks to DOUBLE This Year


GNLN shares were trading at $0.30 per share on Monday afternoon, down $0.01 (-4.27%). Year-to-date, GNLN has gained 4.35%, versus a 8.03% rise in the benchmark S&P 500 index during the same period.


About the Author: Subhasree Kar


Subhasree’s keen interest in financial instruments led her to pursue a career as an investment analyst. After earning a Master’s degree in Economics, she gained knowledge of equity research and portfolio management at Finlatics. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
GNLNGet RatingGet RatingGet Rating
BTIGet RatingGet RatingGet Rating
JAPAYGet RatingGet RatingGet Rating
VGRGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Stock Market Expert Predicts 3-6 Months of Pain

2 important market developments are leading market expert Steve Reitmeister to predict 3 to 6 months of painful market conditions pushing the S&P 500 (SPY) lower. Read on for the full story...

3 Pharmaceutical Stocks Addressing Global Health Challenges

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to pioneering global healthcare solutions. Hence, investing in established pharmaceutical stocks, Pfizer (PFE), Johnson & Johnson (JNJ), and Merck & Co. (MRK) presents a compelling opportunity to capitalize for the long term. Read more...

3 Tech Stocks Analysts Say Are "Strong Buys" for 2025

The technology industry is well-positioned for significant growth thanks to the rapid advancements in emerging technologies and the digitization of business operations. Amid this backdrop, fundamentally solid tech stocks Adobe (ADBE), Leidos Holdings (LDOS), and DocuSign (DOCU) could be strong buys for 2025. Continue reading...

3 Tech Stocks Under $20 With Breakout Potential

The tech sector is the core of innovation, from transforming industries to powering economic progress. Amid this backdrop, investors could consider buying sound under $20 tech stocks Vimeo (VMEO), PubMatic (PUBM), and Eventbrite (EB). Keep reading…

How Bad Will 2025 Be for Stocks?

As January goes...so goes the stock market. And right now that saying bodes poorly for the year ahead. Especially for the S&P 500 (SPY). That is why Steve Reitmeister shares 2 different paths the market could take in 2025 and how to get your portfolio on the right side of the action.

Read More Stories

More Greenlane Holdings, Inc. - (GNLN) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All GNLN News